Moreover, downregulation of TUBB3 contributed to increased PTEN expression, which was beneficial for re-sensitizing docetaxel-resistant prostate cancer cell lines to cabazitaxel [40]. This evidence concerns the gene TUBB3 and prostate carcinoma.